- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07133555
- Original Trial
Safe Spaces 4 Sexual Health (SS4SH)
May 21, 2026 updated by: Johns Hopkins University
Expanding Safe Spaces 4 Sexual Health, a Mobile Van HIV/STI Testing and Care Linkage Strategy, for MSM in Online Spaces
In an earlier study, the study team carried out an HIV/Sexually transmitted infection (STI) testing approach which found men who have sex with men (MSM) at-risk of getting or spreading HIV in online spaces and linked them to testing services on a mobile van.
The goal of this present study is to add on to this approach by connecting participants (MSM aged 18-49 residing in the Baltimore area) with a peer health navigator to support them with getting pre-exposure prophylaxis (PrEP) or HIV care services after testing.
Researchers will compare using a peer health navigator approach to using a referrals-only approach to get PrEP or HIV care services.
Participants will be assigned to either Arm A (group that receives peer health navigator help) or Arm B (group that gets referred) to get PrEP or HIV care.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
In the SS4SH pilot study, utilizing a data-driven approach in partnership with the local health department, the investigators analyzed local public health surveillance data to identify online sex partner meeting spaces frequently reported by (majority Black) MSM newly diagnosed with HIV and/or syphilis.
The identified online spaces were used to advertise mobile van HIV/STI testing for MSM > 18 years of age and less than 49 years of age over a 14-month period.
The strategy and advertisements were informed by a community advisory board (CAB) of MSM hosted at a local Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) community-based organization to ensure local relevance, acceptability and feasibility.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Steven Huettner
- Phone Number: 410 302 2103
- Email: shuettn1@jhmi.edu
Study Contact Backup
- Name: Errol Fields, MD, PhD, MPH
- Phone Number: 14105028317
- Email: errol.fields@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Recruiting
- Johns Hopkins
-
Contact:
- Research Program Manager
- Phone Number: 410-302-2103
- Email: shuettn1@jhmi.edu
-
Contact:
- Senior Research Program Coordinator
- Phone Number: 413-636-7746
- Email: gnewton3@jh.edu
-
Baltimore, Maryland, United States, 21287
- Not yet recruiting
- Johns Hopkins School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male
- 18-49 years of age
- Ability to read and speak English
- Baltimore area resident
- Report sex with a male in the past 12 months
Exclusion Criteria:
- not male-self identified individual
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group receiving peer health navigation follow-up
Participants randomly assigned to Arm A will receive a navigation/care linkage needs assessment followed by peer navigation once weekly after discussing their test results with the navigator to support their linkage to PrEP or HIV care over a six-week period.
Navigators will complete the following care linkage steps: 1) assess interest in linkage, 2) identify preferred clinic for care linkage, and 3) assist with scheduling initial PrEP/HIV provider appointment.
Additionally, the investigators will use the qualitative data collected from in-depth interviews (IRB00375934) of Black MSM and key informant interviews of care linkage stakeholders on barriers and facilitators to HIV prevention and care linkage strategies to inform the peer navigation that Arm A receives.
|
Using peer health navigators to support linkage to HIV prevention and treatment resources among Black MSM in online spaces following mobile testing.
|
|
No Intervention: Control group receiving standard of care referral
Participants randomly assigned to Arm B will go through the standard of care referral process to a local community site providing PrEP or HIV care after discussing their test results with a navigator.
During this discussion with a navigator, participants will receive information about the PrEP/HIV care sites where the participants can go for services.
Six weeks following this initial follow-up, participants will meet virtually with the navigator to complete a PrEP/care linkage status assessment to determine if the participants attended the initial PrEP/HIV provider appointment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of adding care linkage assessed by retention rate
Time Frame: 6 weeks
|
Feasibility of adding care linkage will be measured based on the retention rate during follow-up period of Arm A participants in need of PrEP/HIV care linkage.
Retention rate of 75% will be used as a feasibility threshold.
Linkage is defined as completing a PrEP/HIV care related medical visit within 30 days of enrollment.
|
6 weeks
|
|
Acceptability as assessed by participant satisfaction
Time Frame: 6 weeks
|
A satisfaction rate of 75% or greater will be used as the acceptability threshold.
|
6 weeks
|
|
Acceptability as assessed by number of participants with intent to repeat use of SS4SH
Time Frame: 6 weeks
|
Acceptability will be measured as intention for repeat use of SS4SH testing/care linkage modality.
|
6 weeks
|
|
Effectiveness as assessed by the number of Black MSM linked to HIV/PrEP
Time Frame: 30 days
|
Preliminary data on effectiveness will be assessed by number of Black MSM linked to HIV care and PrEP within 30 days of enrollment.
Linkage is defined as completing a PrEP/HIV care related medical visit.
|
30 days
|
|
Effectiveness as assessed by number of Black MSM lost to followup
Time Frame: 30 days
|
Preliminary data on Effectiveness assessed by number of Black MSM lost to follow up.
Linkage is defined as completing a PrEP/HIV care related medical visit.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach/awareness of the geotargeted advertisement campaign assessed by cost per 1,000 impressions (CPM)
Time Frame: 12 weeks
|
Defined by impressions, cost per 1,000 impressions (CPM)
|
12 weeks
|
|
Website traffic of the geotargeted advertisement campaign assessed by cost per click (CPC)
Time Frame: 12 weeks
|
Defined by clicks, cost per click (CPC)
|
12 weeks
|
|
Cost per action conversion rate of the geotargeted advertisement campaign
Time Frame: 12 weeks
|
Actions will include website actions (view schedule, scheduling appointments) and van actions (HIV/STI testing)
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Errol L Fields, MD, PhD, MPH, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Fields EL, Thornton N, Huettner S, Schumacher C, Barrow G, Greenbaum A, Jennings JM. Safe Spaces 4 Sexual Health: A Status-Neutral, Mobile Van, HIV/STI Testing Intervention Using Online Outreach to Reach MSM at High Risk for HIV Acquisition or Transmission. J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S84-S89. doi: 10.1097/QAI.0000000000002968.
- Rosenberg ES, Millett GA, Sullivan PS, Del Rio C, Curran JW. Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling study. Lancet HIV. 2014 Dec;1(3):e112-e118. doi: 10.1016/S2352-3018(14)00011-3.
- Oster AM, Wiegand RE, Sionean C, Miles IJ, Thomas PE, Melendez-Morales L, Le BC, Millett GA. Understanding disparities in HIV infection between black and white MSM in the United States. AIDS. 2011 May 15;25(8):1103-12. doi: 10.1097/QAD.0b013e3283471efa.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 10, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
August 12, 2025
First Submitted That Met QC Criteria
August 18, 2025
First Posted (Actual)
August 21, 2025
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 21, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00442069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Prevention
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
University of California, Los AngelesRecruitingHIV PreventionUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
Medstar Health Research InstituteNational Institute of Mental Health (NIMH)CompletedHIV Prevention ProgramUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingHIV Prevention | Healthy VolunteerUnited States
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
University of MichiganNational Institute of Mental Health (NIMH)Enrolling by invitationHIV Prevention | Pre-Exposure Prophylaxis (PrEP)United States
Clinical Trials on Healthcare counseling service
-
Seoul National University HospitalTerminatedObesity | Life Style Induced IllnessKorea, Republic of
-
Seoul National University Bundang HospitalCompletedDiabetesKorea, Republic of
-
SK Telecom ConsortiumCompletedDiabetes MellitusKorea, Republic of
-
Seoul National University HospitalKorea Health Industry Development Institute; Seoul National UniversityNot yet recruitingHypertension | Diabete Mellitus
-
Johns Hopkins UniversityUniversity of South Florida; NYU Langone Health; University of Minnesota; National... and other collaboratorsCompleted
-
Amref Health AfricaCompletedSchistosomiasis Infection | Soil Transmitted Helminth (STH) InfectionsKenya
-
Gerencia de Atención Primaria, MadridActive, not recruitingChildhood ObesitySpain
-
NYU Langone HealthMemorial Sloan Kettering Cancer Center; National Institutes of Health (NIH); National...Completed
-
KTO Karatay UniversityCompleted
-
University of Texas Southwestern Medical CenterNational Society of Genetic CounselorsCompletedGenetic PredispositionUnited States